Diagonal Therapeutics News and Activities

Acquisition, funding and merger involving Diagonal Therapeutics.

• Diagonal Therapeutics has just announced a $125 Million fundraising (posted on January 16 2026).

View the org chart displaying its 13 main executives

Most searched biographies at Diagonal Therapeutics

• Alex Lugovskoy, Chief Executive Officer
• Barbara Fox, Director
• Clayton Knox, Director

Popular executive movements at Diagonal Therapeutics

• Jonathan Piazza has joined the company as Chief Financial Officer  (posted on May 8 2026).

Create your alert
to follow the executive moves at Diagonal Therapeutics.

Diagonal Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Diagonal Therapeutics

• Diagonal Therapeutics Expands Executive Leadership Team, Appoints Industry Veteran Jonathan Piazza as Chief Financial Officer | Diagonal Therapeutics

Social media about Diagonal Therapeutics

• Diagonal Therapeutics on Wikipedia, Google News & Yahoo Finance
• Diagonal Therapeutics on LinkedIn, X (Twitter) & YouTube